Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed disodium for recurrent or persistent low-risk gestational trophoblastic tumor after molar pregnancy; the study status is ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Gestational Trophoblastic Tumor | Phase 2 | Status: TERMINATED